Immunohistochemical expression of cathepsin D in correlation with extracellular matrix component, steroid receptor status and proliferative indices in breast cancer

被引:20
作者
Ioachim, E
Kamina, S
Kontostolis, M
Agnantis, NJ
机构
[1] Department of Pathology, Medical School, University of Ioannina
来源
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY | 1997年 / 431卷 / 05期
关键词
collagen type IV; laminin; fibronectin; cathepsin D; breast cancer;
D O I
10.1007/s004280050104
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
In 87 breast cancer patients. the immunohistochemical expression of the basement membrane (BM)degrading enzyme cathepsin D (CD) was correlated with the expression of extracellular matrix components, with growth fraction, steroid receptor content and with the other conventional prognostic variables in breast cancer. Only 6.25% of tumours had laminin-defined BM, while 86.8% showed staining for fibronectin. CD was also identified in carcinoma cells (cancer cell CD; CCCD) and in stromal cells (stromal cell CD; SCCD). Forty-five percent of rumours showed CCCD and 47.5%, SCCD expression. CCCD expression was significantly correlated with positive oestrogen receptor content, with low Ki-67 and high PCNA score and with SCCD expression. There was no correlation with collagen type IV, laminin or fibronectin. SCCD expression was positively correlated with collagen type IV, laminin expression and tumour grade. The data suggest that the CD of tumour cells and the CD of tumour-associated macrophages have different roles in breast cancer. CCCD correlates with cell proliferation and is regulated by oestrogens, while SCCD relates to cell differentiation, is oestrogen-independent, and has a proteolytic role in the breakdown of BM components.
引用
收藏
页码:311 / 316
页数:6
相关论文
共 32 条
[1]  
ALBRECHTSEN R, 1981, CANCER RES, V41, P5076
[2]   PROLIFERATIVE INDEX IN BREAST-CARCINOMA DETERMINED INSITU BY KI67 IMMUNOSTAINING AND ITS RELATIONSHIP TO CLINICAL AND PATHOLOGICAL VARIABLES [J].
BARNARD, NJ ;
HALL, PA ;
LEMOINE, NR ;
KADAR, N .
JOURNAL OF PATHOLOGY, 1987, 152 (04) :287-295
[3]  
BARSKY SH, 1983, LANCET, V1, P296
[4]   CORRELATION OF PROLIFERATIVE ACTIVITY IN BREAST-TISSUE USING PCNA CYCLIN [J].
BATTERSBY, S ;
ANDERSON, TJ .
HUMAN PATHOLOGY, 1990, 21 (07) :781-781
[5]   HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS [J].
BLOOM, HJG ;
RICHARDSON, WW .
BRITISH JOURNAL OF CANCER, 1957, 11 (03) :359-&
[6]   KI67 IMMUNOSTAINING IN PRIMARY BREAST-CANCER - PATHOLOGICAL AND CLINICAL ASSOCIATIONS [J].
BOUZUBAR, N ;
WALKER, KJ ;
GRIFFITHS, K ;
ELLIS, IO ;
ELSTON, CW ;
ROBERTSON, JFR ;
BLAMEY, RW ;
NICHOLSON, RI .
BRITISH JOURNAL OF CANCER, 1989, 59 (06) :943-947
[7]  
BRIOZZO P, 1988, CANCER RES, V48, P3688
[8]   CATHEPSIN-D AND BREAST-CANCER - USEFUL [J].
CARDIFF, RD .
HUMAN PATHOLOGY, 1994, 25 (09) :847-848
[9]  
CHARPIN C, 1986, HUM PATHOL, V17, P335
[10]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410